Skip to main content
. 2018 Nov 15;2018:4013912. doi: 10.1155/2018/4013912

Table 3.

The primary disease of taking XYP of ADR case reports.

Primary disease Number of patients Percentage
Upper respiratory tract infections 17 36.2%
Acute/chronic bronchitis 8 17.0%
Bronchopneumonia 2 4.3%
Amygdalitis 5 10.6%
Pneumonia 4 8.5%
Bronchial asthma 1 2.1%
Bronchiectasia with infections 1 2.1%
Mycoplasma pneumonia 1 2.1%
Acute/chronic bacillary dysentery 1 2.1%
Diarrhea 1 2.1%
Emesis and hypogastralgia 1 2.1%
Adenomesenteritis 1 2.1%
Scald with infections 1 2.1%
Psoriasis 1 2.1%
Fever of unknown origin 2 4.3%
Total 47 100%